George Elston | Chief Financial Officer |
Nancy Lurker | President and Chief Executive Officer |
Jay Duker | Chief Strategic Scientific Officer |
Scott Jones | Chief Commercial Officer |
Dario Paggiarino | Senior Vice President and Chief Medical Officer |
Jennifer Kim | Cantor Fitzgerald |
Dana Flanders | Guggenheim |
Yale Jen | Laidlaw and Company |
Andrew D'Silva | B. Riley |
Good morning. My name is Kevin and I’ll be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals’ Fourth Quarter and Year End 2020 Financial Results and Recent Corporate Development Conference Call. There will be a question-and-answer session to follow with the completion of the prepared remarks. Please be advised that this call is being recorded at the company's request.